Johnson & Johnson to Buy Auris Health for $3.4 Billion
Original Content Publication Date: 02/13/2019
Johnson & Johnson will be acquiring robotic surgery firm, Auris Health for $3.4B. Their purchase acts in support of J&J's recent strategy of dropping out of unprofitable markets and acquiring companies that may give them the advantage in other areas. The robotic surgery market is projected to be valued at $12B by 2025 and J&J is trying to get ahead of the game. Coupling the technology of Auris Health with the funds of J&J, the company hopes to improve and simplify the future of surgery.
- Johnson & Johnson is acquiring robotic surgery company, Auris Health, for $3.4B in cash
- The robotic surgery market is projected to be valued at $12B by 2025 influencing the purchase
- The huge acquisition was fueled by the idea that J&J's implants and solutions could compliment Auris' tech and vice versa
- What benefits do you see for J&J due to their purchase of a robotic surgery company?
- Do you think J&J should invest in robotic surgery when research shows its less favorable than conventional surgery?